id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-347404-nv70mlae	Teixeira da Silva, Jaime A.	Convalescent plasma: A possible treatment of COVID-19 in India	2020-04-15		.txt	text/plain	955	61	57	One postexposure prophylaxis, convalescent (immune) plasma (CP), has shown some success in China and previously in the cure and therapy of other coronaviruses, SARS-1 and Middle East respiratory syndrome. Drawn from current patients who are infected with COVID-19, its CP (human anti–SARS-CoV-2 plasma) might be one way to modulate the infectivity of this virus or its effects postinfection. Lessons learned thus far from the largest outbreaks of this pandemic in China, the US, Italy, and Spain reveal that there is still no cure, although several possible drugs and novel agents, which have not been clinically tested, are available through compassionate use, or as repurposed antiviral and immune-modulating pharmacotherapies. 4 In China, five critically ill patients infected with COVID-19 (also with acute respiratory distress syndrome) received a transfusion of SARS-CoV-2especific IgG (binding titer > 1:1000; neutralization titer > 40) 10e22 days after admission.	./cache/cord-347404-nv70mlae.txt	./txt/cord-347404-nv70mlae.txt